Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus versus mycophenolate mofetil after simultaneous pancreas-kidney transplantation
2019-002240-24Phase 4Active
- Sponsor
- Institute for Clinical and Experimental Medicine
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of sirolimus and mycophenolate mofetil in diabetes mellitus type 1 (T1D), diabetic glomerulosclerosis and end-stage kidney disease (ESKD) (2 arms), sponsored by Institute for Clinical and Experimental Medicine. Started Jun 2019; status: active.
02
Drugs
sirolimusmycophenolate mofetil
03
Conditions
diabetes mellitus type 1 (T1D)diabetic glomerulosclerosisend-stage kidney disease (ESKD)
Beyond the preview
Go deeper on 2019-002240-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002240-24.